Ingredion Agrees £2.7 Billion Bid for Tate & Lyle at 60% Premium
C•Ingredion has agreed to acquire Tate & Lyle for £2.7 billion ($3.6 billion), offering 595 pence per share plus up to 20 pence in dividends, representing a 60% premium. The deal ends Tate & Lyle’s near-century listing on the London Stock Exchange and faces potential regulatory scrutiny over modified starch operations.
1. Deal Terms
Ingredion will acquire Tate & Lyle for £2.7 billion in cash, paying 595 pence per share plus up to 20 pence in special dividends. The offer represents a 60% premium to pre-announcement levels and values the business at $3.6 billion.
2. Market Reaction
Tate & Lyle shares jumped as much as 14% to 560 pence on the announcement but remain below the offer price, reflecting investor concerns over execution risk. Trading levels suggest some market skepticism about deal completion.
3. Regulatory Considerations
The combined entity’s modified starch units may draw scrutiny from competition authorities in the UK and US, raising potential antitrust hurdles. Analysts note that overlapping product lines could prolong regulatory review timelines.
4. London Listing Impact
Tate & Lyle’s near-100-year presence on the London Stock Exchange will end upon deal closure, highlighting ongoing challenges for UK listings. The departure follows a broader trend of corporations shifting listings or accepting takeovers away from London.
